Home›Companies›Biotech & Pharma›Inceptor Bio

Inceptor Bio, LLC

Updated Oct 29, 2026·Latest SEC filing Jan 31, 2025·Suggest an edit

About Inceptor Bio

Inceptor Bio is a private company based in Morrisville, North Carolina, incorporated in 2020 in North Carolina. It has reported $65,651,621 raised in five offerings on Form D since May 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 17, 2025Jan 31, 2025$3,275,000of $3.4M target10$327KEquity, OptionsRule 506(b)Form D ↗
Oct 7, 2022Oct 20, 2022amended Jul 24, 2024$15,875,000fully sold13$1.2MDebtRule 506(b)Form D/A ↗1 earlier filing
Feb 17, 2022Mar 4, 2022$37,731,621of $60.8M target9$4.1MEquityRule 506(b)Form D ↗
Jul 1, 2021Jul 7, 2021$5,520,000of $18.1M target20$276KDebt, Fund interestsRule 506(b), 3(c), 3(c)(1)Form D ↗
Apr 30, 2020May 13, 2020amended Sep 28, 2020$3,250,000fully sold6$541KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, five offerings$65,651,621

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Inceptor Bio's Form D filed Jan 31, 2025.

AM
Abraham Maingi
Executive officer
ES
JL
Jason Lawrence
VP Finance
DH
MS
Matthias Schroff
Executive officer and director
SM
Shailesh Maingi
Director
Also a director at Orthobond.
GF
MG
Mark Gilbert
Director

Earlier filings also listed Michael Nicholson (executive officer, last listed Mar 2022), Matthew Haines (executive officer, last listed Mar 2022), Mark Bamforth (director, last listed Mar 2022) and David Johnston (director, last listed Mar 2022).

Sources

  1. SECInceptor Bio, LLC Form D, filed Oct 20, 2022
  2. SECInceptor Bio, LLC Form D, filed May 13, 2020
  3. SECInceptor Bio, LLC filing history